No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1ia2A, 1.0000, 0.00, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-[(4-METHYLPHENYL)SULFANYL]-24- QUINAZOLINEDIAMINE (GW578)
2, 1ia1A, 0.9992, 0.14, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(PHENYLSULFANYL)-24-QUINAZOLINEDIAMINE (GW997)
3, 1m78A, 0.9991, 0.15, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-CHLORYL-246-QUINAZOLINETRIAMINE (GW1225)
4, 1ia3A, 0.9991, 0.15, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- [(4-TERT-BUTYLPHENYL)SULFANYL]-24-QUINAZOLINEDIAMINE (GW995)
5, 1m79A, 0.9989, 0.16, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(4-METHOXYPHENOXY)-24-QUINAZOLINEDIAMINE (GW1466)
6, 1ia4A, 0.9988, 0.18, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- {[4-(4-MORPHOLINYL)PHENYL]SULFANYL}-24-QUINAZOLINEDIAMIN (GW2021)
7, 1m7aA, 0.9986, 0.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H- PYRROLO[32-F] QUINAZOLINE-13-DIAMINE (GW557)
8, 1aoeA, 0.9981, 0.22, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 13-DIAMINO-7-(1-ETHYEPROPYE)-7H-PYRRALO-[32- F]QUINAZOLINE (GW345)
9, 1ai9A, 0.9975, 0.26, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE
10, 4hoeA, 0.9936, 0.42, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-2 4-DIAMINE (UCP111E)
11, 3qlrA, 0.9936, 0.41, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
12, 4hofA, 0.9907, 0.50, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
13, 3qlsA, 0.9905, 0.51, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
14, 4h97A, 0.9774, 0.61, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-METHOXY-5-(4-METHYLPHENYL)PHENYL]BUT-1-YN-1-YL}-6- METHYLPYRIMIDINE-24-DIAMINE (UCP111D4M)
15, 4h97B, 0.9744, 0.67, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-METHOXY-5-(4-METHYLPHENYL)PHENYL]BUT-1-YN-1-YL}-6- METHYLPYRIMIDINE-24-DIAMINE (UCP111D4M)
16, 3qlwB, 0.9744, 0.72, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP120B)
17, 3qlwA, 0.9741, 0.70, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP120B)
18, 4h96A, 0.9701, 0.65, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
19, 4h95B, 0.9699, 0.66, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL}PYRIMIDINE-24-DIAMINE (UCP1006)
20, 4h95A, 0.9699, 0.66, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL}PYRIMIDINE-24-DIAMINE (UCP1006)
21, 1ia4B, 0.9695, 1.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- {[4-(4-MORPHOLINYL)PHENYL]SULFANYL}-24-QUINAZOLINEDIAMIN (GW2021)
22, 1m79B, 0.9690, 1.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(4-METHOXYPHENOXY)-24-QUINAZOLINEDIAMINE (GW1466)
23, 1ia3B, 0.9685, 1.21, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- [(4-TERT-BUTYLPHENYL)SULFANYL]-24-QUINAZOLINEDIAMINE (GW995)
24, 1ia2B, 0.9675, 1.22, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-[(4-METHYLPHENYL)SULFANYL]-24- QUINAZOLINEDIAMINE (GW578)
25, 4h96B, 0.9668, 0.72, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
26, 1ia1B, 0.9662, 1.23, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(PHENYLSULFANYL)-24-QUINAZOLINEDIAMINE (GW997)
27, 1ai9B, 0.9661, 1.23, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE
28, 1m7aB, 0.9651, 1.24, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H- PYRROLO[32-F] QUINAZOLINE-13-DIAMINE (GW557)
29, 1m78B, 0.9643, 1.25, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-CHLORYL-246-QUINAZOLINETRIAMINE (GW1225)
30, 1aoeB, 0.9635, 1.26, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 13-DIAMINO-7-(1-ETHYEPROPYE)-7H-PYRRALO-[32- F]QUINAZOLINE (GW345)
31, 3qlrB, 0.9616, 1.28, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
32, 4hoeB, 0.9610, 1.29, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-2 4-DIAMINE (UCP111E)
33, 3qlsB, 0.9593, 1.31, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
34, 4hofB, 0.9590, 1.31, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
35, 3eelA, 0.8985, 1.76, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP11153TM) AND NADPH
36, 3qlxA, 0.8978, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
37, 3eemA, 0.8978, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D26M) AND NADPH
38, 3eejB, 0.8978, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-PHENYLPHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D) AND NADPH
39, 3eejA, 0.8978, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-PHENYLPHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D) AND NADPH
40, 3eemB, 0.8976, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D26M) AND NADPH
41, 3eekB, 0.8976, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(4-METHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D4M) AND NADPH
42, 3cseB, 0.8976, 1.76, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
43, 3qlxB, 0.8975, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
44, 3eelB, 0.8974, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP11153TM) AND NADPH
45, 3cseA, 0.8974, 1.77, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
46, 3eekA, 0.8972, 1.78, 0.444, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(4-METHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D4M) AND NADPH
47, 4hogA, 0.8962, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
48, 3roaB, 0.8961, 1.79, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(MORPHOLIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1004)
49, 3roaA, 0.8961, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(MORPHOLIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1004)
50, 3qlyB, 0.8961, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
51, 3qlyA, 0.8961, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
52, 4hogB, 0.8959, 1.78, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
53, 3qlzB, 0.8959, 1.79, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-PROPYLPYRIMIDINE-24- DIAMINE (UCP130B)
54, 3qlzA, 0.8958, 1.79, 0.449, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-PROPYLPYRIMIDINE-24- DIAMINE (UCP130B)
55, 4h98B, 0.8942, 1.75, 0.435, 224, 186, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
56, 3ro9B, 0.8937, 1.83, 0.455, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
57, 3ro9A, 0.8935, 1.84, 0.439, 225, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
58, 4h98A, 0.8919, 1.77, 0.441, 224, 186, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
59, 3cd2A, 0.8833, 1.97, 0.368, 206, 185, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
60, 2fzhA, 0.8825, 2.04, 0.368, 206, 185, NEW INSIGHTS INTO DIHYDROFOLATE REDUCTASE INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
61, 1dyrA, 0.8816, 2.00, 0.362, 205, 185, THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION
62, 4ixeD, 0.8812, 2.02, 0.368, 206, 185, PCDHFR-NADPH-270
63, 1ly4A, 0.8801, 2.02, 0.362, 205, 185, ANALYSIS OF QUINAZOLINE AND PYRIDO[23D]PYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE
64, 1vj3A, 0.8799, 1.82, 0.366, 205, 183, STRUCTURAL STUDIES ON BIO-ACTIVE COMPOUNDS. CRYSTAL STRUCTURE AND MOLECULAR MODELING STUDIES ON THE PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COFACTOR COMPLEX WITH TAB A HIGHLY SELECTIVE ANTIFOLATE.
65, 1ly3A, 0.8799, 2.04, 0.368, 206, 185, ANALYSIS OF QUINAZOLINE AND PYRIDOPYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE
66, 1dajA, 0.8799, 2.16, 0.366, 206, 186, COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS CARINII AND WILD TYPE HUMAN DIHYDROFOLATE REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[23D]PYRIMIDINE ANTIFOLATE
67, 1cd2A, 0.8796, 2.03, 0.368, 206, 185, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
68, 3nzcX, 0.8795, 2.06, 0.368, 206, 185, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIDINE DERIVATIVEA
69, 4qjzD, 0.8793, 2.04, 0.368, 206, 185, PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH NADPH AND THE INHIBITOR 24 (N~6~-METHYL-N~6~-(NAPHTHALEN-1-YL) PYRIDO[23-D]PYRIMIDINE-246-TRIAMINE)
70, 4ixfX, 0.8793, 1.81, 0.366, 206, 183, PCDHFR-269 F69N VARIANT
71, 4g8zX, 0.8792, 1.83, 0.355, 204, 183, PCDHFR K37S/F69N DOUBLE MUTANT TMP NADPH TERNARY COMPLEX
72, 3nzbX, 0.8790, 1.79, 0.372, 206, 183, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF POTENT 5-(OMEGA-CARBOXYL(ALKYLOXY) PYRIDO[2-D]PYRIMIDINE DERIVATIVES
73, 3nz9X, 0.8789, 1.93, 0.370, 206, 184, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
74, 1klkA, 0.8789, 1.94, 0.366, 203, 183, CRYSTAL STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH PT653 AND NADPH
75, 1e26A, 0.8784, 2.08, 0.362, 205, 185, DESIGN SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A POTENT DUAL INHIBITOR OF THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE AS AN ANTITUMOR AGENT.
76, 3nz6X, 0.8782, 1.98, 0.370, 206, 184, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
77, 2cd2A, 0.8782, 1.93, 0.370, 206, 184, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
78, 3nzaX, 0.8781, 1.80, 0.372, 206, 183, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
79, 4ixgX, 0.8777, 1.78, 0.361, 206, 183, PCDHFR-268-K37S-N69F VARIANT
80, 2fziA, 0.8770, 1.84, 0.372, 206, 183, NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
81, 1s3yA, 0.8770, 1.98, 0.370, 206, 184, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
82, 4cd2A, 0.8580, 1.91, 0.372, 202, 180, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
83, 3td8A, 0.8564, 1.44, 0.383, 194, 175, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 24-DIAMINO-5-METHYL-6-[2 -(4-CARBOXY-1- PENTYNYL)-5 -METHOXYBENZYL]PYRIDO[23-D]PYRIMIDINE
84, 3k45A, 0.8260, 2.25, 0.367, 186, 177, ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF 24- DIAMINOFURO[23D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND MOUSE DIHYDROFOLATE REDUCTASE
85, 4m6jA, 0.8235, 2.16, 0.354, 184, 175, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADPH
86, 3k47A, 0.8226, 2.28, 0.367, 186, 177, ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF 24- DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND MOUSE DIHYDROFOLATE REDUCTASE
87, 2c2sA, 0.8226, 2.34, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
88, 3d80A, 0.8222, 2.31, 0.367, 186, 177, STRUCTURAL ANALYSIS OF A HOLO ENZYME COMPLEX OF MOUSE DIHYDROFOLATE REDUCTASE WITH NADPH AND A TERNARY COMPLEX WTIH THE POTENT AND SELECTIVE INHIBITOR 24-DIAMINO-6-(2 -HYDROXYDIBENZ[BF]AZEPIN-5-YL) METHYLPTERIDINE
89, 2w3aA, 0.8222, 2.34, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
90, 2c2tA, 0.8208, 2.35, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-((78-DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
91, 2w3aB, 0.8195, 2.22, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
92, 1dr1A, 0.8183, 2.35, 0.339, 186, 177, 2.2 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADP+ AND BIOPTERIN
93, 8dfrA, 0.8181, 2.36, 0.333, 186, 177, REFINED CRYSTAL STRUCTURES OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE. 3 ANGSTROMS APO-ENZYME AND 1.7 ANGSTROMS NADPH HOLO-ENZYME COMPLEX
94, 1dr3A, 0.8179, 2.36, 0.333, 186, 177, 2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN
95, 2c2sB, 0.8173, 2.25, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
96, 1dr6A, 0.8172, 2.37, 0.339, 186, 177, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
97, 2w3mA, 0.8171, 2.40, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE
98, 1dr5A, 0.8171, 2.24, 0.330, 186, 176, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
99, 1u70A, 0.8170, 2.36, 0.356, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE
100, 1dr4A, 0.8170, 2.24, 0.335, 186, 176, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
101, 4kakB, 0.8168, 2.40, 0.350, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDINE-4-YL)PHENYL]BUT-1- YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
102, 1dr2A, 0.8168, 2.37, 0.333, 186, 177, 2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN
103, 2w3mB, 0.8167, 2.25, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE
104, 2c2tB, 0.8164, 2.26, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-((78-DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
105, 1dr7A, 0.8162, 2.25, 0.335, 186, 176, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
106, 4kbnB, 0.8161, 2.43, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-(35- PYRIMIDINE)]-PHENYL-PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-24DIAMINE
107, 4kbnA, 0.8158, 2.25, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-(35- PYRIMIDINE)]-PHENYL-PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-24DIAMINE
108, 3nxtA, 0.8150, 2.42, 0.345, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E-AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[2M3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
109, 3d84X, 0.8146, 2.39, 0.367, 186, 177, STRUCTURAL ANALYSIS OF A HOLO ENZYME COMPLEX OF MOUSE DIHYDROFOLATE REDUCTASE WITH NADPH AND A TERNARY COMPLEX WITH THE POTENT AND SELECTIVE INHIBITOR 2.4-DIAMINO-6-(-2 -HYDROXYDIBENZ[BF]AZEPIN-5- YL)METHYLPTERIDINE
110, 3nxvA, 0.8140, 2.43, 0.345, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
111, 3um5B, 0.8137, 2.31, 0.309, 544, 175, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS-T9/94) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
112, 4kfjB, 0.8136, 2.42, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]PROP-1-YN-1-YL}6-ETHYLPRIMIDINE-24- DIAMINE
113, 3nxoA, 0.8136, 2.43, 0.339, 186, 177, PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
114, 4kakA, 0.8135, 2.29, 0.347, 186, 176, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDINE-4-YL)PHENYL]BUT-1- YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
115, 4kebB, 0.8131, 2.43, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]BUT-1-YN-1-YL}6-ETHYLPYRIMIDINE-24- DIAMINE
116, 1u71A, 0.8131, 2.47, 0.350, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH
117, 4kebA, 0.8129, 2.28, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]BUT-1-YN-1-YL}6-ETHYLPYRIMIDINE-24- DIAMINE
118, 1bozA, 0.8129, 2.46, 0.350, 186, 177, STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 24- DIAMINO-6-SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS
119, 2w3bB, 0.8127, 2.43, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
120, 4qhvA, 0.8121, 2.44, 0.345, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE AS COMPLEX WITH PYRIDOPYRIMIDINE 22 (N~6~-METHYL-N~6~-[4-(PROPAN-2-YL) PHENYL]PYRIDO[23-D]PYRIMIDINE-246-TRIAMINE)
121, 3dgaB, 0.8120, 2.28, 0.309, 224, 175, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF01302 NADPH AND DUMP
122, 1hfrA, 0.8119, 2.48, 0.350, 186, 177, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
123, 4kfjA, 0.8118, 2.30, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]PROP-1-YN-1-YL}6-ETHYLPRIMIDINE-24- DIAMINE
124, 4m6lA, 0.8117, 2.33, 0.347, 186, 176, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND 510-DIDEAZATETRAHYDROFOLIC ACID
125, 3s3vA, 0.8115, 2.45, 0.356, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE Q35K/N64F DOUBLE MUTANT BINARY COMPLEX WITH TRIMETHOPRIM
126, 1pd8A, 0.8115, 2.48, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
127, 1hfpA, 0.8115, 2.49, 0.345, 186, 177, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
128, 1s3wA, 0.8114, 2.48, 0.350, 186, 177, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOALTES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
129, 3um6B, 0.8113, 2.38, 0.309, 544, 175, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DHFR-TS (T9/94) COMPLEXED WITH CYCLOGUANIL NADPH AND DUMP
130, 3l3rA, 0.8113, 2.45, 0.350, 186, 177, STRUCTURAL COMPUTATIONAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THEIR ACTIVE SITE MUTANTS
131, 1u72A, 0.8113, 2.49, 0.350, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDRFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH
132, 1dlsA, 0.8111, 2.49, 0.345, 186, 177, METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS
133, 1pd9A, 0.8110, 2.50, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
134, 2fzjA, 0.8109, 2.44, 0.367, 186, 177, NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
135, 1hfqA, 0.8109, 2.50, 0.345, 186, 177, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
136, 2w3bA, 0.8108, 2.46, 0.350, 185, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
137, 1dlrA, 0.8107, 2.49, 0.350, 186, 177, METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS
138, 3nxrA, 0.8106, 2.46, 0.345, 186, 177, PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
139, 3n0hA, 0.8106, 2.46, 0.350, 186, 177, HDHFR DOUBLE MUTANT Q35S/N64F TRIMETHOPRIM BINARY COMPLEX
140, 3f8zA, 0.8106, 2.46, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE STRUCTURAL DATA WITH ACTIVE SITE MUTANT ENZYME COMPLEXES
141, 3nxxA, 0.8104, 2.47, 0.345, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO-23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
142, 4dpdB, 0.8103, 2.18, 0.310, 543, 174, WILD TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) DHF COMPLEX NADP+ DUMP
143, 3fs6A, 0.8103, 2.46, 0.345, 186, 177, CORRELATIONS OF INHIBITOR KINETICS FOR PNEUMOCYSTIS JIROVECII AND HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
144, 1mvsA, 0.8103, 2.50, 0.350, 186, 177, ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[23- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
145, 1ohjA, 0.8102, 2.49, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE MONOCLINIC (P21) CRYSTAL FORM
146, 3dg8B, 0.8101, 2.27, 0.305, 221, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF670 NADPH AND DUMP
147, 6de4B, 0.8099, 2.47, 0.345, 186, 177, HOMO SAPIENS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 - [(2R)-4-(2;4-DIAMINO-6-ETHYLPHENYL)BUT-3-YN-2-YL]-5 -METHOXY-[1;1 - BIPHENYL]-4-CARBOXYLIC ACID 
148, 5huiA, 0.8099, 2.50, 0.345, 186, 177, 6-SUBSTITUTED PYRIDO[32-D]PYRIMIDINE--6-4 -TRIFLUOROMETHOXYPHENYL)
149, 3oafA, 0.8097, 2.47, 0.350, 186, 177, STRUCTURAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THIER ACTIVE SITE MUTANTS
150, 6de4A, 0.8096, 2.48, 0.345, 186, 177, HOMO SAPIENS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 - [(2R)-4-(2;4-DIAMINO-6-ETHYLPHENYL)BUT-3-YN-2-YL]-5 -METHOXY-[1;1 - BIPHENYL]-4-CARBOXYLIC ACID 
151, 3f91A, 0.8096, 2.48, 0.350, 186, 177, STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
152, 4qjcA, 0.8094, 2.47, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH NADPH AND INHIBITOR 26 (N~6~-METHYL-N~6~-(345-TRIFLUOROPHENYL)PYRIDO[23-D]PYRIMIDINE- 246-TRIAMINE)
153, 1s3uA, 0.8094, 2.37, 0.347, 186, 176, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
154, 3s7aA, 0.8093, 2.48, 0.348, 186, 178, HUMAN DIHYDROFOLATE REDUCTASE BINARY COMPLEX WITH PT684
155, 5hqzA, 0.8091, 2.48, 0.350, 186, 177, FLUORINE SUBSTITUTED 5-METHYL-6-(4 -TRIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
156, 3f8yA, 0.8091, 2.48, 0.350, 186, 177, CORRELATIONS OF HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
157, 5ht5A, 0.8089, 2.49, 0.345, 186, 177, 6-SUBSTITUTED PYRROLO[23-D]PYRIMIDINE 6-THIENO-(4-METHOXYPHENYL)
158, 4kd7A, 0.8089, 2.35, 0.341, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5(PYRIDINE-4-YL)PHENYL]PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2 4-DIAMINE
159, 4kd7B, 0.8088, 2.37, 0.341, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5(PYRIDINE-4-YL)PHENYL]PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2 4-DIAMINE
160, 3ghwA, 0.8087, 2.49, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE INHIBITOR COMPLEX
161, 5hpbA, 0.8086, 2.50, 0.339, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 5-METHYL-6- (PHENYLTHIO-4 TRIFLUOROMETHYL)THIENO[23-D]PYRIMIDINE-24-DIAMINE
162, 3nu0A, 0.8086, 2.48, 0.345, 186, 177, DESIGN SYNTHESIS BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURE OF NOVEL CLASSICAL 656-TRICYCLICBENZO[45]THIENO[23-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS
163, 2oipA, 0.8086, 2.04, 0.289, 516, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
164, 3nzdA, 0.8085, 2.50, 0.350, 186, 177, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE 5-(OMEGA-CARBOXY(ALKYLOXY(PYRIDO[23- D]PYRIMIDINE DERIVATIVES
165, 3nxyA, 0.8085, 2.49, 0.350, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALERNATE BINDING MODES OBSERVED FRO THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
166, 3ntzA, 0.8085, 2.48, 0.345, 186, 177, DESIGN SYNTHESIS BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURES OF NOVEL CLASSICAL 656-TRICYCLICBENZO[45]THIENO[23-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS
167, 1j3iB, 0.8083, 2.32, 0.309, 226, 175, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
168, 3qgtB, 0.8081, 2.34, 0.309, 542, 175, CRYSTAL STRUCTURE OF WILD-TYPE PFDHFR-TS COMPLEXED WITH NADPH DUMP AND PYRIMETHAMINE
169, 1pdbA, 0.8081, 2.50, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
170, 1j3jB, 0.8081, 2.34, 0.309, 216, 175, DOUBLE MUTANT (C59R+S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
171, 4m6kA, 0.8079, 2.52, 0.350, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND FOLATE
172, 3gyfA, 0.8079, 2.50, 0.345, 186, 177, HUMAN DHFR WITH Z-ISOMER IN ORTHORHOMBIC LATTICE
173, 3dl5A, 0.8079, 2.04, 0.289, 507, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
174, 5ht4A, 0.8074, 2.50, 0.345, 186, 177, 6-SUBSTITUTED PYRROLO[23-D]PYRIMIDINE 6-THIENO-(4-METHOXYPHENYL)
175, 4ky8D, 0.8074, 2.05, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
176, 3qg2B, 0.8074, 2.25, 0.305, 542, 174, PLASMODIUM FALCIPARUM DHFR-TS QRADRUPLE MUTANT (N51I+C59R+S108N+I164L V1/S) PYRIMETHAMINE COMPLEX
177, 3ghcA, 0.8074, 2.51, 0.345, 186, 177, DESIGN SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF CLASSICAL AND NONCLASSICAL 2-AMINO-4-OXO-5-SUBSTITUTED-6-THIENO[23- D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS AND AS POTENTIAL ANTITUMOR AGENST
178, 3gi2A, 0.8072, 2.50, 0.356, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE Q35K MUTANT INHIBITOR COMPLEX
179, 3ghvA, 0.8072, 2.50, 0.356, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE Q35K/N64F DOUBLE MUTANT INHIBITOR COMPLEX
180, 4ky8B, 0.8070, 2.05, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
181, 4g95A, 0.8070, 2.49, 0.345, 186, 177, HDHFR-OAG BINARY COMPLEX
182, 3um8B, 0.8069, 2.39, 0.309, 542, 175, WILD-TYPE PLASMODIUM FALCIPARUM DHFR-TS COMPLEXED WITH CYCLOGUANIL AND NADPH
183, 5hvbA, 0.8067, 2.52, 0.345, 186, 177, 5-METHYL-6-(1-NAPHTHYLTHIO)THIENO[23-D]PYRIMIDINE 24-DIAMINE
184, 1s3vA, 0.8066, 2.41, 0.347, 186, 176, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
185, 3um6A, 0.8064, 2.41, 0.310, 546, 174, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DHFR-TS (T9/94) COMPLEXED WITH CYCLOGUANIL NADPH AND DUMP
186, 6davB, 0.8061, 2.47, 0.347, 186, 176, CRYSTAL STRUCTURE OF HUMAN DHFR COMPLEXED WITH NADP AND N10FORMYLTETRAHYDROFOLATE 
187, 3dl5E, 0.8061, 2.06, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
188, 3dl5D, 0.8061, 2.08, 0.289, 507, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
189, 5hsrA, 0.8060, 2.52, 0.345, 186, 177, FLUORINE SUBSTITUTED 5-METHYL-6-(3 4 -DIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
190, 3dl5B, 0.8058, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
191, 3hj3B, 0.8057, 2.10, 0.289, 510, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
192, 3hj3A, 0.8056, 2.10, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
193, 3dl6D, 0.8054, 2.11, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
194, 4q0eE, 0.8053, 2.08, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
195, 1j3kB, 0.8053, 2.30, 0.305, 221, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
196, 5hqyA, 0.8052, 2.54, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 5-METHYL-6-(2  3 4 -TRIFLUOROPHENYLTHIO)THIENO[23-D]PYRIMIDINE-24-DIAMINE
197, 4ky8A, 0.8052, 2.08, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
198, 4dp3B, 0.8052, 2.23, 0.305, 544, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P218 AND NADPH
199, 3dl6B, 0.8052, 2.11, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
200, 3dl6A, 0.8052, 2.09, 0.289, 505, 173, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
201, 1sejB, 0.8052, 2.10, 0.289, 519, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
202, 1sejA, 0.8052, 2.10, 0.289, 519, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
203, 3um5A, 0.8051, 2.42, 0.310, 546, 174, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS-T9/94) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
204, 1sejC, 0.8051, 2.10, 0.289, 519, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
205, 4q0eC, 0.8050, 2.08, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
206, 4q0eA, 0.8050, 2.08, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
207, 1sejE, 0.8050, 2.10, 0.289, 519, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
208, 4q0eD, 0.8049, 2.08, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
209, 4dphB, 0.8049, 2.34, 0.305, 529, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P65 AND NADPH
210, 1sejD, 0.8049, 2.10, 0.289, 519, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
211, 3jsuB, 0.8048, 2.24, 0.305, 542, 174, QUADRUPLE MUTANT(N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE(PFDHFR-TS) COMPLEXED WITH QN254 NADPH AND DUMP
212, 6davA, 0.8047, 2.47, 0.347, 186, 176, CRYSTAL STRUCTURE OF HUMAN DHFR COMPLEXED WITH NADP AND N10FORMYLTETRAHYDROFOLATE 
213, 4q0eB, 0.8047, 2.09, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
214, 4ky8E, 0.8046, 2.09, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
215, 3dl6E, 0.8046, 2.10, 0.289, 507, 173, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
216, 5hveA, 0.8044, 2.54, 0.345, 186, 177, 5-METHYL-6-(3 -TRIFLUROMETHOXYPHENYLTHIO)[23-D]PYRIMIDINE 24-DIAMINE
217, 2oipD, 0.8044, 2.09, 0.289, 515, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
218, 2oipC, 0.8044, 2.10, 0.289, 514, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
219, 3dl6C, 0.8043, 2.11, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
220, 2oipB, 0.8043, 2.13, 0.289, 516, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
221, 1qzfD, 0.8043, 2.12, 0.289, 519, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
222, 1qzfC, 0.8043, 2.12, 0.289, 519, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
223, 1qzfB, 0.8043, 2.12, 0.289, 519, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
224, 1qzfA, 0.8043, 2.12, 0.289, 519, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
225, 1qzfE, 0.8042, 2.12, 0.289, 519, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
226, 4q0dE, 0.8041, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
227, 4q0dD, 0.8041, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
228, 4q0dC, 0.8041, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
229, 4q0dB, 0.8041, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
230, 4q0dA, 0.8041, 2.09, 0.289, 508, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
231, 4ky8C, 0.8041, 2.10, 0.289, 505, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
232, 1kmsA, 0.8041, 2.41, 0.354, 184, 175, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ([5-QUINOLYLAMINO]METHYL)-24-DIAMINO-5-METHYLPYRIDO[23- D]PYRIMIDINE (SRI-9439) A LIPOPHILIC ANTIFOLATE
233, 4ddrA, 0.8040, 2.54, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND P218
234, 3dl5C, 0.8036, 2.12, 0.289, 508, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
235, 5hsuA, 0.8035, 2.54, 0.345, 186, 177, FLUORINE SUBSTITUTED 5-METHYL-6-(2 4 -DIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
236, 3dg8A, 0.8031, 2.43, 0.305, 221, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF670 NADPH AND DUMP
237, 1mvtA, 0.8031, 2.45, 0.347, 186, 176, ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[23- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
238, 1dhfA, 0.8031, 2.28, 0.353, 182, 173, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
239, 3qgtA, 0.8030, 2.44, 0.310, 547, 174, CRYSTAL STRUCTURE OF WILD-TYPE PFDHFR-TS COMPLEXED WITH NADPH DUMP AND PYRIMETHAMINE
240, 1dhfB, 0.8030, 2.30, 0.353, 182, 173, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
241, 4dpdA, 0.8027, 2.43, 0.310, 530, 174, WILD TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) DHF COMPLEX NADP+ DUMP
242, 2oipE, 0.8020, 2.11, 0.289, 511, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
243, 1j3jA, 0.8017, 2.45, 0.310, 221, 174, DOUBLE MUTANT (C59R+S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
244, 1kmvA, 0.8016, 2.59, 0.339, 185, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)- 6-(2-[25-DIMETHOXYPHENYL]ETHEN-1-YL)-24-DIAMINO-5- METHYLPYRIDO[23-D]PYRIMIDINE (SRI-9662) A LIPOPHILIC ANTIFOLATE
245, 3um8A, 0.8014, 2.44, 0.310, 547, 174, WILD-TYPE PLASMODIUM FALCIPARUM DHFR-TS COMPLEXED WITH CYCLOGUANIL AND NADPH
246, 2dhfB, 0.8014, 2.31, 0.353, 182, 173, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
247, 3jsuA, 0.8011, 2.44, 0.305, 545, 174, QUADRUPLE MUTANT(N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE(PFDHFR-TS) COMPLEXED WITH QN254 NADPH AND DUMP
248, 2dhfA, 0.8011, 2.30, 0.353, 182, 173, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
249, 1j3iA, 0.8009, 2.45, 0.310, 223, 174, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
250, 3qg2A, 0.8008, 2.46, 0.305, 547, 174, PLASMODIUM FALCIPARUM DHFR-TS QRADRUPLE MUTANT (N51I+C59R+S108N+I164L V1/S) PYRIMETHAMINE COMPLEX
251, 3dgaA, 0.8008, 2.47, 0.310, 219, 174, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF01302 NADPH AND DUMP
252, 1j3kA, 0.8005, 2.46, 0.305, 221, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
253, 1drfA, 0.8002, 2.66, 0.350, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
254, 1ohkA, 0.7999, 2.50, 0.358, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE ORTHORHOMBIC (P21 21 21) CRYSTAL FORM
255, 3qfxA, 0.7996, 2.41, 0.316, 219, 174, TRYPANOSOMA BRUCEI DIHYDROFOLATE REDUCTASE PYRIMETHAMINE COMPLEX
256, 3invB, 0.7993, 2.50, 0.301, 513, 176, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH DUMP AND C-448 ANTIFOLATE
257, 3hj3C, 0.7991, 2.23, 0.289, 510, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
258, 4dphA, 0.7982, 2.50, 0.305, 538, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P65 AND NADPH
259, 3invA, 0.7982, 2.53, 0.301, 514, 176, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH DUMP AND C-448 ANTIFOLATE
260, 3hj3D, 0.7982, 2.22, 0.289, 505, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
261, 3irmA, 0.7977, 2.57, 0.301, 520, 176, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH CYCLOGUANIL
262, 3qfxB, 0.7972, 2.48, 0.309, 218, 175, TRYPANOSOMA BRUCEI DIHYDROFOLATE REDUCTASE PYRIMETHAMINE COMPLEX
263, 1yhoA, 0.7964, 2.46, 0.335, 186, 176, SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH 25 STRUCTURES
264, 4dp3A, 0.7963, 2.52, 0.305, 545, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P218 AND NADPH
265, 3kjrA, 0.7961, 2.12, 0.269, 498, 171, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS DETERMINED USING SLIPCHIP BASED MICROFLUIDICS
266, 3kjsD, 0.7953, 2.53, 0.301, 504, 176, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
267, 2h2qA, 0.7950, 2.58, 0.301, 514, 176, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE
268, 3kjsC, 0.7949, 2.55, 0.301, 507, 176, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
269, 3clbC, 0.7948, 2.54, 0.301, 510, 176, STRUCTURE OF BIFUNCTIONAL TCDHFR-TS IN COMPLEX WITH TMQ
270, 3irnA, 0.7944, 2.53, 0.301, 516, 176, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND CYCLOGUANIL
271, 3kjrB, 0.7940, 2.13, 0.269, 495, 171, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS DETERMINED USING SLIPCHIP BASED MICROFLUIDICS
272, 3irnC, 0.7939, 2.67, 0.294, 516, 177, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND CYCLOGUANIL
273, 3hbbC, 0.7939, 2.56, 0.301, 510, 176, STRUCTURES OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE OF TRYPANOSOMA CRUZI IN THE FOLATE-FREE STATE AND IN COMPLEX WITH TWO ANTIFOLATE DRUGS TRIMETREXATE AND METHOTREXATE
274, 3rg9B, 0.7936, 2.66, 0.312, 218, 176, TRYPANOSOMA BRUCEI DIHYDROFOLATE REDUCTASE (TBDHFR) IN COMPLEX WITH WR99210
275, 3clbD, 0.7935, 2.55, 0.301, 509, 176, STRUCTURE OF BIFUNCTIONAL TCDHFR-TS IN COMPLEX WITH TMQ
276, 3hbbA, 0.7933, 2.45, 0.297, 510, 175, STRUCTURES OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE OF TRYPANOSOMA CRUZI IN THE FOLATE-FREE STATE AND IN COMPLEX WITH TWO ANTIFOLATE DRUGS TRIMETREXATE AND METHOTREXATE
277, 3clbA, 0.7931, 2.45, 0.297, 510, 175, STRUCTURE OF BIFUNCTIONAL TCDHFR-TS IN COMPLEX WITH TMQ
278, 3hbbD, 0.7928, 2.57, 0.301, 507, 176, STRUCTURES OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE OF TRYPANOSOMA CRUZI IN THE FOLATE-FREE STATE AND IN COMPLEX WITH TWO ANTIFOLATE DRUGS TRIMETREXATE AND METHOTREXATE
279, 3nrrB, 0.7927, 2.12, 0.269, 501, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP RALTITREXED AND NADP
280, 3iroA, 0.7927, 2.68, 0.294, 518, 177, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND Q-8 ANTIFOLATE
281, 3rg9A, 0.7926, 2.53, 0.314, 218, 175, TRYPANOSOMA BRUCEI DIHYDROFOLATE REDUCTASE (TBDHFR) IN COMPLEX WITH WR99210
282, 3nrrA, 0.7926, 2.13, 0.269, 503, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP RALTITREXED AND NADP
283, 2bl9A, 0.7926, 2.55, 0.299, 216, 174, X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE
284, 2blcA, 0.7920, 2.56, 0.299, 215, 174, SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH DES-CHLOROPYRIMETHAMINE
285, 3kjsA, 0.7913, 2.52, 0.297, 500, 175, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
286, 3irnB, 0.7909, 2.56, 0.303, 516, 175, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND CYCLOGUANIL
287, 3irmC, 0.7907, 2.66, 0.301, 516, 176, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH CYCLOGUANIL
288, 2blaA, 0.7899, 2.53, 0.301, 217, 173, SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE
289, 3kjsB, 0.7894, 2.48, 0.299, 499, 174, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
290, 3iroD, 0.7894, 2.49, 0.310, 513, 174, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND Q-8 ANTIFOLATE
291, 4kyaA, 0.7886, 2.27, 0.318, 510, 170, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
292, 2blbA, 0.7886, 2.58, 0.299, 217, 174, X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE
293, 3irmB, 0.7885, 2.56, 0.303, 519, 175, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH CYCLOGUANIL
294, 4eilC, 0.7884, 2.27, 0.318, 510, 170, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
295, 4kyaE, 0.7883, 2.27, 0.318, 510, 170, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
296, 4kyaC, 0.7882, 2.28, 0.318, 510, 170, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
297, 3clbB, 0.7882, 2.48, 0.297, 508, 175, STRUCTURE OF BIFUNCTIONAL TCDHFR-TS IN COMPLEX WITH TMQ
298, 5t0lB, 0.7881, 2.27, 0.318, 510, 170, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII TS-DHFR COMPLEXED WITH NADPH DUMP PDDF AND 5-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PYRIMIDINE-2 4-DIAMINE (TRC-15)
299, 5t0lA, 0.7881, 2.27, 0.318, 508, 170, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII TS-DHFR COMPLEXED WITH NADPH DUMP PDDF AND 5-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PYRIMIDINE-2 4-DIAMINE (TRC-15)
300, 3eigA, 0.7881, 2.64, 0.335, 186, 176, CRYSTAL STRUCTURE OF A METHOTREXATE-RESISTANT MUTANT OF HUMAN DIHYDROFOLATE REDUCTASE
301, 4kyaG, 0.7878, 2.26, 0.318, 510, 170, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
302, 4eilE, 0.7878, 2.27, 0.324, 510, 170, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
303, 3irmD, 0.7878, 2.54, 0.310, 513, 174, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH CYCLOGUANIL
304, 4eilA, 0.7873, 2.28, 0.318, 510, 170, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
305, 3iroB, 0.7870, 2.58, 0.303, 515, 175, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND Q-8 ANTIFOLATE
306, 4eilG, 0.7868, 2.28, 0.318, 510, 170, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
307, 3hbbB, 0.7868, 2.44, 0.310, 505, 174, STRUCTURES OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE OF TRYPANOSOMA CRUZI IN THE FOLATE-FREE STATE AND IN COMPLEX WITH TWO ANTIFOLATE DRUGS TRIMETREXATE AND METHOTREXATE
308, 3k2hA, 0.7867, 2.19, 0.269, 503, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP PEMETREXED AND NADP
309, 3iroC, 0.7858, 2.60, 0.303, 516, 175, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND Q-8 ANTIFOLATE
310, 3irnD, 0.7856, 2.55, 0.310, 513, 174, TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE COMPLEXED WITH NADPH AND CYCLOGUANIL
311, 3cl9A, 0.7830, 2.65, 0.312, 505, 176, STRUCTURE OF BIFUNCTIONAL TCDHFR-TS IN COMPLEX WITH MTX
312, 3k2hB, 0.7794, 2.31, 0.269, 503, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP PEMETREXED AND NADP
313, 3i3rA, 0.7600, 2.15, 0.256, 489, 164, X-RAY STRUCTURE DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS AT 2.35A RESOLUTION
314, 4eckA, 0.7587, 2.26, 0.335, 498, 164, CRYSTAL STRUCTURE OF THE TOXOPLASMA GONDII TS-DHFR
315, 4eckB, 0.7585, 2.32, 0.329, 498, 164, CRYSTAL STRUCTURE OF THE TOXOPLASMA GONDII TS-DHFR
316, 3vcoA, 0.7562, 3.05, 0.324, 183, 176, SCHISTOSOMA MANSONI DIHYDROFOLATE REDUCTASE
317, 3i3rB, 0.7521, 2.21, 0.252, 477, 163, X-RAY STRUCTURE DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS AT 2.35A RESOLUTION
318, 4kyaH, 0.7414, 1.96, 0.331, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
319, 4kyaD, 0.7413, 1.97, 0.325, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
320, 4kyaB, 0.7413, 1.97, 0.331, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
321, 4kyaF, 0.7412, 1.97, 0.325, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
322, 4eilH, 0.7412, 1.94, 0.325, 491, 157, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
323, 4eilD, 0.7407, 1.95, 0.331, 491, 157, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
324, 4eilF, 0.7405, 1.94, 0.325, 491, 157, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
325, 4ky4E, 0.7402, 1.97, 0.325, 489, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
326, 4ky4A, 0.7401, 1.97, 0.331, 489, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
327, 4ky4H, 0.7399, 1.98, 0.331, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
328, 4ky4C, 0.7398, 1.98, 0.331, 489, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
329, 4eilB, 0.7393, 1.99, 0.325, 491, 157, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
330, 4ky4F, 0.7390, 1.97, 0.325, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
331, 4ky4B, 0.7388, 1.97, 0.325, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
332, 4ky4D, 0.7384, 1.98, 0.325, 491, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
333, 4ky4G, 0.7381, 1.99, 0.325, 489, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
334, 3ia5B, 0.7381, 2.11, 0.344, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR)
335, 3jwkB, 0.7374, 2.56, 0.340, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
336, 3sa2B, 0.7369, 2.57, 0.346, 165, 162, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1014
337, 3sa1B, 0.7363, 2.57, 0.346, 165, 162, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1021
338, 3saiB, 0.7361, 2.58, 0.346, 165, 162, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP1015
339, 3jwmB, 0.7361, 2.58, 0.346, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
340, 3jwkA, 0.7361, 2.57, 0.340, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
341, 3jvxB, 0.7361, 2.57, 0.346, 166, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345-TRIMETHOXYPHENYL) PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
342, 3s9uB, 0.7360, 2.57, 0.346, 165, 162, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP120J
343, 3jwcB, 0.7359, 2.58, 0.340, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
344, 3sa2A, 0.7357, 2.58, 0.346, 165, 162, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1014
345, 3e0bB, 0.7357, 2.57, 0.346, 166, 162, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2 4-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
346, 3jwmA, 0.7351, 2.60, 0.346, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
347, 3jvxA, 0.7351, 2.59, 0.346, 166, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345-TRIMETHOXYPHENYL) PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
348, 3saiA, 0.7349, 2.60, 0.346, 165, 162, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP1015
349, 3jwcA, 0.7345, 2.46, 0.342, 165, 161, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
350, 3jwfB, 0.7344, 2.60, 0.340, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (R)-24-DIAMINO-5-(3-HYDROXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP113A)
351, 3s9uA, 0.7342, 2.59, 0.346, 165, 162, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP120J
352, 3e0bA, 0.7342, 2.59, 0.346, 166, 162, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2 4-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
353, 3sa1A, 0.7337, 2.48, 0.348, 164, 161, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1021
354, 3jw5A, 0.7334, 2.61, 0.340, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
355, 3jw5B, 0.7328, 2.48, 0.342, 165, 161, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
356, 3jwfA, 0.7327, 2.49, 0.342, 165, 161, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (R)-24-DIAMINO-5-(3-HYDROXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP113A)
357, 5t7oB, 0.7326, 2.80, 0.319, 495, 166, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE IN COMPLEX WITH (6S)-5678-TETRAHYDROFOLATE
358, 3jw3B, 0.7324, 2.62, 0.352, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (F96I) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
359, 3jw3A, 0.7318, 2.63, 0.352, 165, 162, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (F96I) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
360, 3ia5A, 0.7285, 2.26, 0.340, 159, 156, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR)
361, 5t7oA, 0.7284, 2.59, 0.315, 494, 162, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE IN COMPLEX WITH (6S)-5678-TETRAHYDROFOLATE
362, 2w3vA, 0.7280, 2.77, 0.294, 165, 163, MYCOBACTERIUM AVIUM DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
363, 2zzaB, 0.7260, 2.28, 0.344, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE COMPLEX WITH NADP+ AND FOLATE
364, 5t7oD, 0.7259, 2.61, 0.309, 489, 162, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE IN COMPLEX WITH (6S)-5678-TETRAHYDROFOLATE
365, 2zzaA, 0.7259, 2.29, 0.350, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE COMPLEX WITH NADP+ AND FOLATE
366, 4eleF, 0.7257, 2.42, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
367, 2w3wA, 0.7256, 2.73, 0.302, 164, 162, MYCOBACTERIUM AVIUM DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR M. AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
368, 3ia4A, 0.7253, 2.30, 0.344, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
369, 3ix9A, 0.7250, 2.40, 0.262, 166, 160, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE DIHYDROFOLATE REDUCTASE - SP9 MUTANT
370, 4elbF, 0.7248, 2.38, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
371, 4elfF, 0.7246, 2.42, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
372, 2h2qB, 0.7246, 2.70, 0.315, 492, 162, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE
373, 4elhF, 0.7243, 2.43, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
374, 4m7uA, 0.7236, 2.72, 0.280, 170, 161, DIHYDROFOLATE REDUCTASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH NADP(H)
375, 3dfrA, 0.7236, 2.43, 0.253, 162, 158, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
376, 5t7oC, 0.7232, 2.77, 0.307, 487, 163, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE IN COMPLEX WITH (6S)-5678-TETRAHYDROFOLATE
377, 3ia4B, 0.7232, 2.34, 0.344, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
378, 4elgF, 0.7229, 2.45, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
379, 1diuA, 0.7229, 2.43, 0.253, 162, 158, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-46-DICARBOXYLATE
380, 4elbG, 0.7227, 2.45, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
381, 1disA, 0.7227, 2.44, 0.253, 162, 158, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-46-DICARBOXYLATE
382, 3ix9B, 0.7223, 2.47, 0.264, 166, 159, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE DIHYDROFOLATE REDUCTASE - SP9 MUTANT
383, 4elbB, 0.7222, 2.46, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
384, 3fl8F, 0.7222, 2.47, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
385, 4elhB, 0.7220, 2.47, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
386, 3ia4D, 0.7219, 2.38, 0.344, 161, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
387, 3tq8A, 0.7218, 2.45, 0.259, 171, 158, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH TRIMETHOPRIM
388, 3ia4C, 0.7218, 2.41, 0.344, 160, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
389, 3fl8A, 0.7218, 2.48, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
390, 3fl8B, 0.7217, 2.48, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
391, 3fl8G, 0.7215, 2.48, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
392, 4elhG, 0.7214, 2.47, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
393, 4elgB, 0.7213, 2.47, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
394, 4elbE, 0.7213, 2.48, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
395, 3fl8E, 0.7212, 2.48, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
396, 4elgG, 0.7211, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
397, 3fl8D, 0.7209, 2.49, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
398, 4elhE, 0.7208, 2.50, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
399, 2qk8A, 0.7207, 2.53, 0.352, 162, 159, CRYSTAL STRUCTURE OF THE ANTHRAX DRUG TARGET BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
400, 4elhD, 0.7206, 2.50, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
401, 4eleB, 0.7206, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
402, 3fl8C, 0.7206, 2.49, 0.352, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
403, 3r33A, 0.7205, 2.19, 0.303, 159, 155, EVIDENCE FOR DYNAMIC MOTION IN PROTEINS AS A MECHANISM FOR LIGAND DISSOCIATION
404, 4elfG, 0.7204, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
405, 4elgA, 0.7203, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
406, 4elfB, 0.7203, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
407, 4eleG, 0.7203, 2.49, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
408, 3kfyA, 0.7200, 2.20, 0.303, 159, 155, DYNAMIC SWITCHING AND PARTIAL OCCUPANCIES OF A SMALL MOLECULE INHIBITOR COMPLEX OF DHFR
409, 4elhA, 0.7199, 2.51, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
410, 4elfE, 0.7199, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
411, 3tqaA, 0.7199, 2.48, 0.268, 158, 157, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH NADPH
412, 4elgD, 0.7198, 2.51, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
413, 4elgE, 0.7196, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
414, 4eleD, 0.7196, 2.51, 0.346, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
415, 4eleE, 0.7194, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
416, 4eleA, 0.7194, 2.53, 0.340, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
417, 4elfA, 0.7193, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
418, 4elbC, 0.7193, 2.51, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
419, 4elgH, 0.7191, 2.49, 0.340, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
420, 4elfD, 0.7191, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
421, 4elbD, 0.7191, 2.51, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
422, 5uioD, 0.7189, 2.27, 0.306, 160, 157, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
423, 4elhH, 0.7187, 2.52, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
424, 4elbA, 0.7187, 2.52, 0.358, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
425, 2anqA, 0.7182, 2.22, 0.303, 159, 155, CRYSTAL STRUCTURE OF E.COLI DHFR IN COMPLEX WITH NADPH AND THE INHIBITOR COMPOUND 10A.
426, 4osgA, 0.7178, 2.06, 0.305, 159, 154, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
427, 1ao8A, 0.7176, 2.48, 0.253, 162, 158, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE NMR 21 STRUCTURES
428, 5w3qA, 0.7175, 2.06, 0.305, 159, 154, L28F E.COLI DHFR IN COMPLEX WITH NADPH
429, 4elbH, 0.7175, 2.50, 0.340, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
430, 1rx1A, 0.7175, 2.07, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
431, 4elhC, 0.7173, 2.53, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
432, 1rx9A, 0.7173, 2.06, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
433, 4eleH, 0.7172, 2.52, 0.340, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
434, 4elfH, 0.7168, 2.55, 0.340, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
435, 1rx3A, 0.7168, 2.18, 0.310, 159, 155, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
436, 4elgC, 0.7165, 2.54, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
437, 4eleC, 0.7164, 2.54, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
438, 3fl9D, 0.7164, 2.46, 0.342, 165, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
439, 1zdrA, 0.7164, 2.24, 0.301, 161, 153, DHFR FROM BACILLUS STEAROTHERMOPHILUS
440, 4elfC, 0.7162, 2.54, 0.352, 166, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
441, 3qyoA, 0.7162, 2.24, 0.303, 159, 155, SENSITIVITY OF RECEPTOR INTERNAL MOTIONS TO LIGAND BINDING AFFINITY AND KINETIC OFF-RATE
442, 3datA, 0.7159, 2.60, 0.352, 161, 159, CRYSTAL STRUCTURE OF THE TERNARY MTX NADPH COMPLEX OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
443, 4km0B, 0.7155, 2.83, 0.269, 161, 160, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PYRIMETHAMINE
444, 4km0A, 0.7151, 2.84, 0.269, 161, 160, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PYRIMETHAMINE
445, 2anoA, 0.7149, 2.10, 0.305, 159, 154, CRYSTAL STRUCTURE OF E.COLI DIHYDROFOLATE REDUCTASE IN COMPLEX WITH NADPH AND THE INHIBITOR MS-SH08-17
446, 3ql3A, 0.7148, 2.09, 0.305, 159, 154, RE-REFINED COORDINATES FOR PDB ENTRY 1RX2
447, 4gh8B, 0.7147, 2.28, 0.312, 162, 157, CRYSTAL STRUCTURE OF A  HUMANIZED  E. COLI DIHYDROFOLATE REDUCTASE
448, 4osgC, 0.7146, 2.28, 0.310, 159, 155, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
449, 4pdjA, 0.7143, 2.10, 0.305, 159, 154, NEUTRON CRYSTAL STRUCTURE OF E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NADP+
450, 4p3qA, 0.7142, 2.10, 0.305, 159, 154, ROOM-TEMPERATURE WT DHFR TIME-AVERAGED ENSEMBLE
451, 4klxA, 0.7141, 2.94, 0.273, 161, 161, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION.
452, 1rx2A, 0.7140, 2.10, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
453, 1rx8A, 0.7138, 2.10, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2 - MONOPHOSPHOADENOSINE 5 -DIPHOSPHORIBOSE
454, 1drhA, 0.7137, 2.20, 0.303, 159, 155, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
455, 4nx6A, 0.7129, 2.11, 0.305, 159, 154, SINGLE ROOM TEMPERATURE MODEL OF DHFR
456, 7dfrA, 0.7128, 2.32, 0.308, 159, 156, CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. THE NADP+ HOLOENZYME AND THE FOLATE(DOT)NADP+ TERNARY COMPLEX. SUBSTRATE BINDING AND A MODEL FOR THE TRANSITION STATE
457, 4or7A, 0.7126, 2.35, 0.308, 165, 156, KLEBSIELLA PNEUMONIAE DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-{3-[3-(PYRIMIDIN-5-YL)PHENYL]PROP-1-YN-1-YL}PYRIMIDINE-24- DIAMINE
458, 3fl9C, 0.7126, 2.54, 0.354, 165, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
459, 3dauA, 0.7124, 2.33, 0.308, 159, 156, CRYSTAL STRUCTURE OF THE TERNARY MTX NADPH COMPLEX OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
460, 2d0kB, 0.7124, 2.50, 0.293, 159, 157, METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
461, 4p3rA, 0.7122, 2.30, 0.308, 159, 156, CRYOGENIC WT DHFR TIME-AVERAGED ENSEMBLE
462, 3fl9F, 0.7122, 2.53, 0.342, 165, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
463, 4km2B, 0.7121, 2.84, 0.277, 159, 159, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION IN COMPLEX WITH TRIMETHOPRIM
464, 4gh8A, 0.7119, 2.24, 0.314, 162, 156, CRYSTAL STRUCTURE OF A  HUMANIZED  E. COLI DIHYDROFOLATE REDUCTASE
465, 3qylA, 0.7118, 2.20, 0.303, 159, 155, SENSITIVITY OF RECEPTOR INTERNAL MOTIONS TO LIGAND BINDING AFFINITY AND KINETIC OFF-RATE
466, 4nx7A, 0.7117, 2.20, 0.303, 159, 155, SINGLE CRYOGENIC TEMPERATURE MODEL OF DHFR
467, 1dreA, 0.7117, 2.34, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
468, 4km2A, 0.7116, 2.90, 0.277, 159, 159, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION IN COMPLEX WITH TRIMETHOPRIM
469, 1rh3A, 0.7115, 2.23, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
470, 4m7vA, 0.7114, 2.62, 0.285, 168, 158, DIHYDROFOLATE REDUCTASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH NADP(H)AND RAB-PROPYL
471, 3fl9G, 0.7114, 2.47, 0.344, 164, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
472, 3fl9H, 0.7113, 2.48, 0.357, 164, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
473, 3fl9E, 0.7110, 2.49, 0.357, 164, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
474, 4p66A, 0.7109, 2.10, 0.301, 158, 153, ELECTROSTATICS OF ACTIVE SITE MICROENVIRONMENTS OF E. COLI DHFR
475, 4klxB, 0.7106, 2.91, 0.275, 160, 160, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION.
476, 3sh2A, 0.7106, 2.25, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(4-METHOXYBIPHENYL-3-YL)PROP-1-YNYL)PYRIMIDINE-24- DIAMINE (UCP120J)
477, 4p68A, 0.7105, 2.11, 0.301, 158, 153, ELECTROSTATICS OF ACTIVE SITE MICROENVIRONMENTS FOR E. COLI DHFR
478, 4fggA, 0.7105, 2.40, 0.284, 163, 155, S. AUREUS DIHYDROFOLATE REDUCTASE CO-CRYSTALLIZED WITH PROPYL-DAP ISOBUTENYL-DIHYDROPHTHALAZINE INHIBITOR
479, 3sh2B, 0.7105, 2.25, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(4-METHOXYBIPHENYL-3-YL)PROP-1-YNYL)PYRIMIDINE-24- DIAMINE (UCP120J)
480, 1bzfA, 0.7104, 2.38, 0.269, 162, 156, NMR SOLUTION STRUCTURE AND DYNAMICS OF THE COMPLEX OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE 22 STRUCTURES
481, 2lf1A, 0.7103, 2.39, 0.268, 162, 157, SOLUTION STRUCTURE OF L. CASEI DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH 30 STRUCTURES
482, 3fl9A, 0.7102, 2.53, 0.363, 164, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
483, 4osgB, 0.7100, 2.17, 0.305, 159, 154, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
484, 4fghA, 0.7098, 2.42, 0.284, 163, 155, S. AUREUS DIHYDROFOLATE REDUCTASE CO-CRYSTALLIZED WITH ETHYL-DAP ISOBUTENYL-DIHYDROPHTHALAZINE INHIBITOR
485, 4rgcA, 0.7093, 2.11, 0.307, 158, 153, 277K CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
486, 3fqcA, 0.7092, 2.29, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]-6- METHYLPYRIMIDINE (UCP115A)
487, 4ptjA, 0.7091, 2.10, 0.307, 158, 153, ENSEMBLE MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 277K
488, 3lg4A, 0.7089, 2.42, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS V31Y F92I MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-[(3S)-3-(5-METHOXY-2 6 -DIMETHYLBIPHENYL- 3-YL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24-DIAMINE
489, 3lg4B, 0.7088, 2.42, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS V31Y F92I MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-[(3S)-3-(5-METHOXY-2 6 -DIMETHYLBIPHENYL- 3-YL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24-DIAMINE
490, 1zdrB, 0.7088, 2.35, 0.296, 160, 152, DHFR FROM BACILLUS STEAROTHERMOPHILUS
491, 4x5fB, 0.7086, 2.30, 0.301, 160, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 0.1 MPA
492, 3frfX, 0.7085, 2.35, 0.286, 158, 154, S. AUREUS DHFR COMPLEXED WITH NADPH AND ICLAPRIM
493, 1ludA, 0.7081, 2.50, 0.253, 162, 158, SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH 24 STRUCTURES
494, 4kneB, 0.7079, 2.95, 0.277, 159, 159, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CYCLOGUANIL
495, 3fy9X, 0.7079, 2.36, 0.292, 157, 154, STAPH. AUREUS DHFR F98Y COMPLEXED WITH AR-102
496, 3fraX, 0.7079, 2.36, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y DHFR COMPLEXED WITH ICLAPRIM
497, 3fqcB, 0.7079, 2.31, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]-6- METHYLPYRIMIDINE (UCP115A)
498, 5eccB, 0.7077, 2.39, 0.282, 157, 156, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(2- METHOXY-5-(PYRIDIN-4-YL)PHENYL)PROP-1-YN-1-YL)PYRIMIDINE-24-DIAMINE
499, 4psyA, 0.7076, 2.22, 0.312, 158, 154, 100K CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
500, 5ecxB, 0.7075, 2.39, 0.282, 157, 156, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(6- (PYRIDIN-4-YL)BENZO[D][13]DIOXOL-4-YL)BUT-1-YN-1-YL)PYRIMIDINE-24- DIAMINE
501, 3fy8X, 0.7075, 2.37, 0.292, 157, 154, CRYSTAL STRUCTURE OF STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR- 101
502, 1vdrA, 0.7075, 2.15, 0.242, 157, 153, DIHYDROFOLATE REDUCTASE
503, 3ql0A, 0.7074, 2.40, 0.308, 160, 156, CRYSTAL STRUCTURE OF N23PP/S148A MUTANT OF E. COLI DIHYDROFOLATE REDUCTASE
504, 4x5gB, 0.7072, 2.31, 0.301, 160, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 270 MPA
505, 2d0kA, 0.7071, 2.34, 0.297, 159, 155, METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
506, 4osgD, 0.7070, 2.35, 0.297, 159, 155, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
507, 3f0vX, 0.7070, 2.41, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(26-DIMETHYLPHENYL) PHENYL)BUT-1-YNYL]-6-METHYLPYRIMIDINE
508, 3fyvX, 0.7067, 2.38, 0.286, 158, 154, STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR-102
509, 4lekX, 0.7066, 2.38, 0.286, 157, 154, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
510, 5uioA, 0.7065, 2.43, 0.306, 160, 157, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
511, 4kneA, 0.7065, 2.94, 0.277, 159, 159, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CYCLOGUANIL
512, 3sqyX, 0.7065, 2.37, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
513, 4lagX, 0.7064, 2.38, 0.286, 157, 154, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
514, 4laeX, 0.7064, 2.38, 0.286, 157, 154, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
515, 3srsX, 0.7064, 2.37, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
516, 3srrX, 0.7064, 2.37, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
517, 3freX, 0.7064, 2.37, 0.286, 157, 154, S. AUREUS DHFR COMPLEXED WITH NADPH AND TMP
518, 3fq0A, 0.7063, 2.37, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
519, 4tu5X, 0.7062, 2.40, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1062)
520, 4q6aA, 0.7062, 2.39, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS V31L F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH
521, 4kl9A, 0.7062, 2.70, 0.280, 160, 157, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN THE SPACE GROUP C2
522, 3srwX, 0.7061, 2.38, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
523, 1re7A, 0.7061, 2.38, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
524, 5isqX, 0.7060, 2.38, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS H30N F98Y DIHYDROFOLATE REDUCTASE MUTANT COMPLEXED WITH BETA-NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5- YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1106)
525, 3sr5X, 0.7060, 2.38, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
526, 3f0bX, 0.7059, 2.42, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-PHENYLPHENYL)BUT-1-YNYL]-6- METHYLPYRIMIDINE
527, 5ecxA, 0.7058, 2.44, 0.282, 157, 156, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(6- (PYRIDIN-4-YL)BENZO[D][13]DIOXOL-4-YL)BUT-1-YN-1-YL)PYRIMIDINE-24- DIAMINE
528, 3fywX, 0.7058, 2.39, 0.286, 158, 154, STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR-101
529, 3f0qX, 0.7058, 2.42, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)BUT-1-YNYL]- 6-METHYLPYRIMIDINE
530, 4lahX, 0.7057, 2.39, 0.286, 157, 154, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
531, 2w9gA, 0.7057, 2.40, 0.286, 157, 154, WILD-TYPE STAPHYLOCOCCUS AUREUS DHFR IN COMPLEX WITH NADPH AND TRIMETHOPRIM
532, 4qlgA, 0.7055, 2.27, 0.297, 159, 155, CRYSTAL STRUCTURE OF I14V DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
533, 4q67A, 0.7055, 2.39, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH
534, 3sruX, 0.7055, 2.38, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
535, 3i8aX, 0.7055, 2.39, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS H30N F98Y DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6- ETHYLPYRIMIDINE (UCP120B)
536, 3f0uX, 0.7055, 2.42, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-PHENYLPHENYL)BUT-1- YNYL]-6-METHYLPYRIMIDINE
537, 3frbX, 0.7052, 2.38, 0.292, 157, 154, S. AUREUS F98Y DHFR COMPLEXED WITH TMP
538, 5jg0X, 0.7051, 2.41, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND UCP1191
539, 5hf0X, 0.7051, 2.40, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH CYCLIC ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6- ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4- CARBOXYLIC ACID (UCP1106)
540, 4pthA, 0.7051, 2.34, 0.310, 158, 155, ENSEMBLE MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 100K
541, 3srqX, 0.7051, 2.40, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
542, 5istX, 0.7050, 2.39, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH CYCLIC ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6- ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4- CARBOXYLIC ACID (UCP1106)
543, 1rd7A, 0.7050, 2.39, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
544, 5eccA, 0.7048, 2.45, 0.282, 157, 156, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(2- METHOXY-5-(PYRIDIN-4-YL)PHENYL)PROP-1-YN-1-YL)PYRIMIDINE-24-DIAMINE
545, 3m08A, 0.7048, 2.42, 0.286, 161, 154, WILD TYPE DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS WITH INHIBITOR RAB1
546, 1re7B, 0.7048, 2.46, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
547, 3sgyB, 0.7046, 2.33, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
548, 5ispX, 0.7045, 2.40, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y DIHYDROFOLATE REDUCTASE MUTANT COMPLEXED WITH BETA-NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2- YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1106)
549, 3m09A, 0.7045, 2.42, 0.292, 161, 154, F98Y TMP-RESISTANT DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS WITH INHIBITOR RAB1
550, 3fqfA, 0.7045, 2.44, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]- 6-METHYLPYRIMIDINE (UCP115A)
551, 3f0xX, 0.7045, 2.43, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(35-DIMETHYLPHENYL) PHENYL)BUT-1-YNYL]-6-METHYLPYRIMIDINE
552, 1dyiB, 0.7045, 2.41, 0.308, 159, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
553, 3sgyA, 0.7044, 2.34, 0.301, 157, 153, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
554, 3f0sX, 0.7044, 2.43, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)BUT-1-YNYL]- 6-METHYLPYRIMIDINE
555, 4qleA, 0.7043, 2.30, 0.297, 159, 155, CRYSTAL STRUCTURE OF I14A DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
556, 1ra8A, 0.7043, 2.46, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2- MONOPHOSPHOADENOSINE 5 -DIPHOSPHORIBOSE
557, 2w9hA, 0.7042, 2.42, 0.286, 157, 154, WILD-TYPE STAPHYLOCOCCUS AUREUS DHFR IN COMPLEX WITH TRIMETHOPRIM
558, 6e4eA, 0.7041, 2.50, 0.284, 159, 155, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS MW2 BOUND TO NADP AND P218 
559, 2w9sB, 0.7041, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
560, 2w9sA, 0.7041, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
561, 2w9sC, 0.7040, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
562, 2hm9A, 0.7039, 2.52, 0.269, 162, 156, SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM 33 STRUCTURES
563, 1dyjB, 0.7037, 2.43, 0.308, 159, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
564, 5hf2X, 0.7036, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH CYCLIZED ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP- 2-YN-1-YL)-5 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1175)
565, 3fqoA, 0.7034, 2.43, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(25-DIMETHOXYPHENYL)PROP-1-YNYL]-6- ETHYLPYRIMIDINE (UCP120B)
566, 4xecX, 0.7033, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1061)
567, 4xe6X, 0.7033, 2.44, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1061)
568, 4kjjA, 0.7033, 2.04, 0.298, 153, 151, CRYOGENIC WT DHFR
569, 3fqzA, 0.7033, 2.46, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-4-PHENYLPHENYL)BUT-1-YNYL]-6- METHYLPYRIMIDINE
570, 1ra2A, 0.7033, 2.32, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
571, 1dyhB, 0.7032, 2.33, 0.303, 159, 155, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
572, 5uioC, 0.7028, 2.46, 0.306, 160, 157, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
573, 6ddsB, 0.7027, 2.77, 0.280, 159, 157, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
574, 6ddsA, 0.7026, 2.77, 0.280, 159, 157, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
575, 3fqvA, 0.7026, 2.44, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-4-PHENYLPHENYL)BUT-1- YNYL]-6-METHYLPYRIMIDINE
576, 6ddsC, 0.7024, 2.77, 0.280, 159, 157, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
577, 1ra3A, 0.7024, 2.48, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
578, 4x5fA, 0.7023, 2.34, 0.303, 159, 155, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 0.1 MPA
579, 1rb2B, 0.7023, 2.42, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
580, 3frdX, 0.7022, 2.43, 0.286, 157, 154, S. AUREUS DHFR COMPLEXED WITH NADPH AND FOLATE
581, 2drcB, 0.7022, 2.44, 0.301, 159, 156, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
582, 3fl8H, 0.7021, 1.93, 0.360, 157, 150, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
583, 4fhbA, 0.7020, 2.31, 0.303, 159, 155, ENHANCING DHFR CATALYSIS BY BINDING OF AN ALLOSTERIC REGULATOR NANOBODY (NB179)
584, 1rb2A, 0.7020, 2.34, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
585, 1dhiB, 0.7020, 2.45, 0.308, 159, 156, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
586, 1ra9A, 0.7018, 2.34, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
587, 1ddsB, 0.7015, 2.46, 0.308, 159, 156, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE
588, 3drcB, 0.7013, 2.45, 0.308, 159, 156, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
589, 6ddsD, 0.7012, 2.65, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
590, 1ra1A, 0.7011, 2.35, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
591, 5eajB, 0.7009, 2.46, 0.308, 159, 156, CRYSTAL STRUCTURE OF DHFR IN 0% ISOPROPANOL
592, 4dfrB, 0.7009, 2.46, 0.308, 159, 156, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
593, 1rd7B, 0.7009, 2.36, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
594, 4kjlA, 0.7007, 2.08, 0.318, 157, 151, ROOM TEMPERATURE N23PPS148A DHFR
595, 1draB, 0.7007, 2.47, 0.314, 159, 156, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
596, 4x5gA, 0.7006, 2.34, 0.303, 159, 155, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 270 MPA
597, 1jolB, 0.7006, 2.36, 0.303, 159, 155, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
598, 1dg5A, 0.7006, 2.58, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND TRIMETHOPRIM
599, 5u26A, 0.7004, 2.84, 0.277, 166, 159, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND TO NADP AND P218 INHIBITOR
600, 1ddrB, 0.7004, 2.50, 0.301, 159, 156, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA
601, 4x5jA, 0.7003, 2.47, 0.301, 159, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 750 MPA
602, 4x5iA, 0.7002, 2.47, 0.301, 159, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 660 MPA
603, 4x5hA, 0.7002, 2.47, 0.301, 159, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 500 MPA
604, 1tdrB, 0.7002, 2.47, 0.308, 159, 156, EXPRESSION CHARACTERIZATION AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE
605, 4kjkA, 0.7001, 2.21, 0.309, 156, 152, ROOM TEMPERATURE WT DHFR
606, 1d1gB, 0.7001, 2.73, 0.220, 164, 159, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
607, 1dg7A, 0.7000, 2.58, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND 4-BROMO WR99210
608, 3fl9B, 0.6998, 2.52, 0.355, 158, 155, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
609, 1d1gA, 0.6998, 2.75, 0.220, 164, 159, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
610, 6ddpA, 0.6996, 2.69, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
611, 1rb3B, 0.6996, 2.46, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
612, 1drbB, 0.6995, 2.47, 0.308, 159, 156, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
613, 5ujxB, 0.6994, 2.48, 0.308, 159, 156, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
614, 5uioE, 0.6994, 2.48, 0.301, 160, 156, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
615, 5u27A, 0.6994, 2.84, 0.277, 166, 159, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND TO NADP AND P65 INHIBITOR
616, 5e8qB, 0.6994, 2.48, 0.308, 159, 156, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
617, 6ddpC, 0.6993, 2.69, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
618, 5uipA, 0.6990, 2.52, 0.301, 159, 156, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
619, 1rf7A, 0.6990, 2.49, 0.303, 159, 155, STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDROFOLATE
620, 1dhjB, 0.6990, 2.41, 0.303, 159, 155, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
621, 6ddwA, 0.6989, 2.69, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND N-(4-{[(2-AMINO-4-OXO-3;4-DIHYDROPTERIDIN-6-YL) METHYL]AMINO}-2-HYDROXYBENZENE-1-CARBONYL)-L-GLUTAMIC ACID 
622, 1dg8A, 0.6988, 2.59, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH
623, 6ddpB, 0.6987, 2.69, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
624, 2cigA, 0.6987, 2.60, 0.277, 159, 155, DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS INHIBITED BY THE ACYCLIC 4R ISOMER OF INH-NADP A DERIVATIVE OF THE PRODRUG ISONIAZID.
625, 1df7A, 0.6987, 2.57, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND METHOTREXATE
626, 4i1nA, 0.6985, 2.47, 0.303, 159, 155, R104A-CA1697 NANOBODY BINDING TO THE BINARY DHFR.FOLATE COMPLEX
627, 3ochB, 0.6985, 2.49, 0.308, 159, 156, CHEMICALLY SELF-ASSEMBLED ANTIBODY NANORINGS (CSANS): DESIGN AND CHARACTERIZATION OF AN ANTI-CD3 IGM BIOMIMETIC
628, 6ddpD, 0.6982, 2.70, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
629, 2w9sF, 0.6981, 2.40, 0.288, 157, 153, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
630, 2w9sD, 0.6979, 2.40, 0.288, 157, 153, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
631, 2inqB, 0.6977, 2.47, 0.308, 159, 156, NEUTRON CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BOUND TO THE ANTI-CANCER DRUG METHOTREXATE
632, 1rb3A, 0.6977, 2.40, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
633, 5uiiA, 0.6976, 2.39, 0.303, 159, 155, STRUCTURE OF DHFR WITH BOUND BUFORMIN AND NADP
634, 1rc4A, 0.6975, 2.49, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
635, 1cz3A, 0.6975, 2.76, 0.226, 164, 159, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
636, 5ja3C, 0.6973, 2.74, 0.276, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
637, 2w9sE, 0.6973, 2.41, 0.288, 157, 153, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
638, 1rx6A, 0.6973, 2.46, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
639, 1rx4A, 0.6972, 2.46, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND 2 -MONOPHOSPHOADENOSINE 5 - DIPHOSPHORIBOSE
640, 5uioB, 0.6969, 2.43, 0.301, 160, 156, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
641, 5uipB, 0.6968, 2.38, 0.303, 159, 155, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
642, 5ja3B, 0.6966, 2.76, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
643, 1rx7A, 0.6966, 2.44, 0.305, 159, 154, STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
644, 5ja3D, 0.6965, 2.61, 0.277, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
645, 1dyiA, 0.6963, 2.58, 0.301, 159, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
646, 5ja3A, 0.6960, 2.63, 0.277, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
647, 4i13A, 0.6960, 2.50, 0.303, 159, 155, NANOBODY CA1697 BINDING TO THE DHFR.FOLATE BINARY COMPLEX
648, 1rx5A, 0.6960, 2.47, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE
649, 4qleB, 0.6959, 2.40, 0.297, 159, 155, CRYSTAL STRUCTURE OF I14A DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
650, 1cz3B, 0.6957, 2.76, 0.220, 168, 159, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
651, 4m2xG, 0.6948, 2.63, 0.277, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
652, 4ej1B, 0.6946, 2.51, 0.305, 159, 154, BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX
653, 4eizB, 0.6946, 2.56, 0.303, 159, 155, STRUCTURE OF NB113 BOUND TO APODHFR
654, 1dyhA, 0.6946, 2.45, 0.303, 159, 155, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
655, 5cccA, 0.6945, 2.51, 0.303, 159, 155, WILD-TYPE E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
656, 4eigA, 0.6940, 2.62, 0.310, 159, 155, CA1698 CAMEL ANTIBODY FRAGMENT IN COMPLEX WITH DHFR
657, 1dyjA, 0.6937, 2.46, 0.303, 159, 155, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
658, 2drcA, 0.6936, 2.47, 0.297, 159, 155, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
659, 5eajA, 0.6935, 2.40, 0.299, 159, 154, CRYSTAL STRUCTURE OF DHFR IN 0% ISOPROPANOL
660, 4eizA, 0.6934, 2.70, 0.301, 159, 156, STRUCTURE OF NB113 BOUND TO APODHFR
661, 4ej1A, 0.6933, 2.67, 0.308, 159, 156, BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX
662, 1tdrA, 0.6932, 2.46, 0.303, 159, 155, EXPRESSION CHARACTERIZATION AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE
663, 5ujxA, 0.6930, 2.40, 0.299, 159, 154, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
664, 1jomA, 0.6929, 2.38, 0.307, 159, 153, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
665, 5e8qA, 0.6927, 2.41, 0.299, 159, 154, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
666, 5cc9A, 0.6926, 2.54, 0.310, 159, 155, L28F E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
667, 4qlgB, 0.6923, 2.40, 0.292, 159, 154, CRYSTAL STRUCTURE OF I14V DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
668, 4dfrA, 0.6923, 2.57, 0.308, 159, 156, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
669, 1draA, 0.6921, 2.42, 0.305, 159, 154, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
670, 4m2xC, 0.6919, 2.75, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
671, 1jolA, 0.6919, 2.49, 0.303, 159, 155, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
672, 3drcA, 0.6917, 2.49, 0.303, 159, 155, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
673, 1dhiA, 0.6914, 2.49, 0.303, 159, 155, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
674, 1dhjA, 0.6911, 2.50, 0.303, 159, 155, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
675, 5dfrA, 0.6910, 2.26, 0.307, 154, 150, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
676, 3ochA, 0.6909, 2.54, 0.303, 159, 155, CHEMICALLY SELF-ASSEMBLED ANTIBODY NANORINGS (CSANS): DESIGN AND CHARACTERIZATION OF AN ANTI-CD3 IGM BIOMIMETIC
677, 1vdrB, 0.6908, 2.17, 0.233, 154, 150, DIHYDROFOLATE REDUCTASE
678, 1drbA, 0.6908, 2.44, 0.299, 159, 154, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
679, 1ddsA, 0.6902, 2.45, 0.299, 159, 154, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE
680, 4m2xA, 0.6900, 2.71, 0.277, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
681, 5ujfA, 0.6891, 3.00, 0.285, 161, 158, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND P218 INHIBITOR
682, 4m2xE, 0.6887, 2.83, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
683, 3zpcA, 0.6884, 2.86, 0.131, 357, 160, ACINETOBACTER BAUMANNII RIBD FORM 1
684, 3tq9A, 0.6881, 2.39, 0.273, 151, 150, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH METHOTREXATE
685, 1rg7A, 0.6880, 2.62, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE
686, 3k74A, 0.6879, 2.74, 0.308, 159, 156, DISRUPTION OF PROTEIN DYNAMICS BY AN ALLOSTERIC EFFECTOR ANTIBODY
687, 1ddrA, 0.6878, 2.52, 0.303, 159, 155, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA
688, 3zpcB, 0.6861, 2.99, 0.130, 356, 161, ACINETOBACTER BAUMANNII RIBD FORM 1
689, 3tqbA, 0.6856, 2.41, 0.273, 151, 150, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH FOLATE
690, 4xt8A, 0.6854, 3.03, 0.125, 246, 160, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NADP+ AND TRIMETREXATE
691, 2inqA, 0.6851, 2.50, 0.305, 158, 154, NEUTRON CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BOUND TO THE ANTI-CANCER DRUG METHOTREXATE
692, 5xuxF, 0.6847, 2.93, 0.138, 238, 159, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
693, 6dfrA, 0.6846, 2.29, 0.313, 154, 150, CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. THE NADP+ HOLOENZYME AND THE FOLATE(DOT)NADP+ TERNARY COMPLEX. SUBSTRATE BINDING AND A MODEL FOR THE TRANSITION STATE
694, 5xuxA, 0.6844, 2.94, 0.138, 238, 159, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
695, 6de5A, 0.6842, 3.06, 0.112, 246, 161, MYCOBACTERIUM TUBERCULOSIS RV2671 COMPLEXED WITH BETA-NADPH AND 6- ETHYL-5-{(3S)-3-[2-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL}PYRIMIDINE-2;4-DIAMINE 
696, 6cxmB, 0.6837, 2.90, 0.266, 155, 154, CRYSTAL STRUCTURE OF A DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH NADP AND P218 
697, 2hqpA, 0.6836, 2.91, 0.261, 162, 157, SOLUTION STRUCTURE OF L.CASEI DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH 32 STRUCTURES
698, 4xt4A, 0.6834, 3.02, 0.119, 246, 160, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTEIRUM TUBERCULOSIS IN COMPLEX WITH DIHYDROPTERIDINE RING OF DIHYDROPTEROIC ACID
699, 5xv0A, 0.6832, 2.95, 0.138, 238, 159, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
700, 3zpgA, 0.6830, 2.92, 0.132, 354, 159, ACINETOBACTER BAUMANNII RIBD FORM 2
701, 5xuxB, 0.6827, 2.99, 0.138, 224, 159, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
702, 5xv0B, 0.6826, 2.97, 0.138, 224, 159, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
703, 5xv0C, 0.6824, 3.08, 0.132, 224, 159, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
704, 5xv0F, 0.6821, 2.83, 0.139, 239, 158, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
705, 4xt7A, 0.6819, 3.02, 0.119, 246, 160, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NADP+ AND TRIMETHOPRIM
706, 2d5nB, 0.6819, 2.83, 0.120, 359, 158, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
707, 5uihA, 0.6815, 2.45, 0.289, 159, 152, STRUCTURE OF DHFR WITH BOUND PHENFORMIN AND NADP
708, 5xv0E, 0.6814, 2.90, 0.133, 223, 158, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
709, 5xuxE, 0.6814, 2.91, 0.133, 223, 158, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
710, 5xv5B, 0.6810, 3.00, 0.138, 224, 159, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
711, 5xv0D, 0.6810, 3.10, 0.126, 223, 159, CRYSTAL STRUCTURE OF RIB7 MUTANT D33N FROM METHANOSARCINA MAZEI 
712, 6cxmA, 0.6809, 2.57, 0.265, 155, 151, CRYSTAL STRUCTURE OF A DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH NADP AND P218 
713, 5xuxD, 0.6809, 2.91, 0.133, 223, 158, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
714, 5xv5F, 0.6803, 2.86, 0.139, 227, 158, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
715, 4g3mC, 0.6803, 3.01, 0.119, 361, 160, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
716, 5xuxC, 0.6798, 2.93, 0.133, 224, 158, CRYSTAL STRUCTURE OF RIB7 FROM METHANOSARCINA MAZEI 
717, 5xv2A, 0.6795, 2.93, 0.133, 223, 158, CRYSTAL STRUCTURE OF RIB7 MUTANT D33A FROM METHANOSARCINA MAZEI 
718, 4pstA, 0.6790, 2.07, 0.308, 151, 146, MULTICONFORMER MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 277 K
719, 3ex8C, 0.6786, 3.05, 0.119, 359, 160, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
720, 2p4gA, 0.6781, 2.85, 0.114, 246, 158, CRYSTAL STRUCTURE OF A PYRIMIDINE REDUCTASE-LIKE PROTEIN (DIP1392) FROM CORYNEBACTERIUM DIPHTHERIAE NCTC AT 2.30 A RESOLUTION
721, 2b3zC, 0.6779, 3.21, 0.117, 359, 162, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
722, 4xt5A, 0.6777, 3.05, 0.106, 246, 160, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NADP+
723, 2l28A, 0.6771, 2.93, 0.266, 162, 158, SOLUTION STRUCTURE OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE APO- FORM 25 CONFORMERS
724, 2w9tA, 0.6769, 2.91, 0.286, 159, 154, STAPHYLOCOCCUS AUREUS S1:DHFR
725, 4g3mB, 0.6767, 3.22, 0.117, 361, 162, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
726, 2b3zB, 0.6767, 3.11, 0.118, 359, 161, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
727, 3ex8B, 0.6765, 3.11, 0.118, 359, 161, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
728, 2jybA, 0.6764, 2.61, 0.227, 162, 154, BINARY HVDHFR1:FOLATE COMPLEX
729, 2w9tB, 0.6761, 2.92, 0.286, 159, 154, STAPHYLOCOCCUS AUREUS S1:DHFR
730, 2b3zA, 0.6760, 3.08, 0.119, 359, 160, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
731, 5xv5E, 0.6759, 2.92, 0.134, 222, 157, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
732, 3ex8A, 0.6759, 3.09, 0.125, 359, 160, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
733, 2d5nC, 0.6758, 3.11, 0.118, 359, 161, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
734, 1juvA, 0.6755, 2.80, 0.186, 193, 156, CRYSTAL STRUCTURE ANALYSIS OF DIHYDROFOLATE REDUCTASE FROM BACTERIOPHAGE T4
735, 5xv5C, 0.6753, 2.93, 0.134, 222, 157, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
736, 2b3zD, 0.6748, 3.09, 0.125, 360, 160, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
737, 5xv5D, 0.6747, 3.14, 0.118, 226, 161, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
738, 5hi6A, 0.6742, 2.51, 0.298, 154, 151, THE HIGH RESOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEX WITH METHOTREXATE AS CLOSED FORM
739, 5xv5A, 0.6741, 3.14, 0.118, 231, 161, CRYSTAL STRUCTURE OF RIB7 MUTANT S88E FROM METHANOSARCINA MAZEI 
740, 2d5nA, 0.6741, 3.32, 0.116, 359, 164, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
741, 2obcB, 0.6738, 3.19, 0.093, 353, 162, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH A SUBSTRATE ANALOGUE RIBOSE 5-PHOSPHATE (BETA FORM) BOUND TO THE ACTIVE SITE OF THE REDUCTASE DOMAIN
742, 4g3mD, 0.6730, 3.09, 0.125, 361, 160, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
743, 3ex8D, 0.6728, 3.27, 0.123, 360, 162, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
744, 4g3mA, 0.6721, 3.16, 0.118, 361, 161, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
745, 2d5nD, 0.6719, 3.18, 0.118, 360, 161, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
746, 2g6vB, 0.6711, 3.28, 0.086, 354, 163, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI
747, 4xrbA, 0.6670, 3.02, 0.108, 246, 157, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTERIUM TUBERCULOSIS
748, 3kgyB, 0.6655, 3.12, 0.156, 210, 160, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_001636057.1) FROM CHLOROFLEXUS AURANTIACUS J-10-FL AT 1.50 A RESOLUTION
749, 4qlfA, 0.6649, 2.72, 0.291, 157, 151, CRYSTAL STRUCTURE OF I14G DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
750, 2aznA, 0.6645, 3.05, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
751, 3kgyA, 0.6634, 3.15, 0.144, 210, 160, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_001636057.1) FROM CHLOROFLEXUS AURANTIACUS J-10-FL AT 1.50 A RESOLUTION
752, 2hxvA, 0.6633, 2.80, 0.162, 344, 154, CRYSTAL STRUCTURE OF A DIAMINOHYDROXYPHOSPHORIBOSYLAMINOPYRIMIDINE DEAMINASE/ 5-AMINO-6-(5-PHOSPHORIBOSYLAMINO)URACIL REDUCTASE (TM1828) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION
753, 2aznE, 0.6633, 3.11, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
754, 2aznD, 0.6628, 3.12, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
755, 2aznB, 0.6627, 3.09, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
756, 2aznC, 0.6622, 3.10, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
757, 2aznF, 0.6621, 3.14, 0.101, 214, 158, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
758, 2o7pA, 0.6608, 3.35, 0.081, 349, 161, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH THE OXIDISED NADP+ COFACTOR IN THE ACTIVE SITE OF THE REDUCTASE DOMAIN
759, 2obcA, 0.6598, 3.46, 0.081, 345, 161, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH A SUBSTRATE ANALOGUE RIBOSE 5-PHOSPHATE (BETA FORM) BOUND TO THE ACTIVE SITE OF THE REDUCTASE DOMAIN
760, 5hi6B, 0.6597, 2.69, 0.300, 155, 150, THE HIGH RESOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEX WITH METHOTREXATE AS CLOSED FORM
761, 2g6vA, 0.6591, 3.36, 0.081, 346, 160, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI
762, 2ithA, 0.6579, 2.79, 0.242, 162, 153, NMR STRUCTURE OF HALOFERAX VOLCANII DHFR
763, 4ha9A, 0.6547, 3.10, 0.135, 219, 156, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
764, 2xw7B, 0.6532, 3.41, 0.126, 174, 159, STRUCTURE OF MYCOBACTERIUM SMEGMATIS PUTATIVE REDUCTASE MS0308
765, 4xt6A, 0.6528, 3.02, 0.111, 237, 153, CRYSTAL STRUCTURE OF RV2671 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THE TETRAHYDROPTERIDINE RING OF TETRAHYDROFOLATE (THF)
766, 4ha7A, 0.6518, 3.07, 0.135, 221, 155, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
767, 3jtwA, 0.6515, 3.42, 0.196, 173, 158, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_805003.1) FROM PEDIOCOCCUS PENTOSACEUS ATCC 25745 AT 1.90 A RESOLUTION
768, 4qi9B, 0.6514, 2.20, 0.296, 154, 142, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
769, 3jtwB, 0.6510, 3.42, 0.209, 169, 158, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_805003.1) FROM PEDIOCOCCUS PENTOSACEUS ATCC 25745 AT 1.90 A RESOLUTION
770, 2o7pB, 0.6502, 3.21, 0.083, 345, 156, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH THE OXIDISED NADP+ COFACTOR IN THE ACTIVE SITE OF THE REDUCTASE DOMAIN
771, 4qi9A, 0.6481, 2.21, 0.298, 153, 141, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
772, 2xw7A, 0.6439, 3.16, 0.116, 175, 155, STRUCTURE OF MYCOBACTERIUM SMEGMATIS PUTATIVE REDUCTASE MS0308
773, 3ky8A, 0.6388, 3.32, 0.120, 178, 158, CRYSTAL STRUCTURE OF PUTATIVE RIBOFLAVIN BIOSYNTHESIS PROTEIN (YP_001092907.1) FROM SHEWANELLA SP. PV-4 AT 2.12 A RESOLUTION
774, 3ky8B, 0.6355, 3.29, 0.154, 171, 156, CRYSTAL STRUCTURE OF PUTATIVE RIBOFLAVIN BIOSYNTHESIS PROTEIN (YP_001092907.1) FROM SHEWANELLA SP. PV-4 AT 2.12 A RESOLUTION
775, 3q1hA, 0.6319, 3.36, 0.263, 161, 152, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS
776, 4qi9C, 0.6310, 2.24, 0.297, 149, 138, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
777, 2kgkA, 0.6194, 3.61, 0.293, 162, 157, SOLUTION STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
778, 2gd9B, 0.6168, 3.32, 0.154, 167, 149, CRYSTAL STRUCTURE OF A PUTATIVE DIHYDROFOLATE REDUCTASE (BSU40760 YYAP) FROM BACILLUS SUBTILIS AT 2.30 A RESOLUTION
779, 2gd9A, 0.6116, 3.30, 0.155, 173, 148, CRYSTAL STRUCTURE OF A PUTATIVE DIHYDROFOLATE REDUCTASE (BSU40760 YYAP) FROM BACILLUS SUBTILIS AT 2.30 A RESOLUTION
780, 5fdaA, 0.6065, 3.57, 0.257, 154, 148, THE HIGH RESOLUTION STRUCTURE OF APO FORM DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS AT 1.55 A
781, 4ha7B, 0.6064, 3.76, 0.136, 205, 154, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
782, 4ha9B, 0.6040, 3.72, 0.137, 204, 153, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
783, 5dxvA, 0.5436, 2.82, 0.309, 148, 123, CRYSTAL STRUCTURE OF RETHREADED DHFR
784, 5dxvB, 0.5427, 2.86, 0.309, 144, 123, CRYSTAL STRUCTURE OF RETHREADED DHFR
785, 3bh1D, 0.5316, 4.73, 0.051, 487, 157, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
786, 3bh1A, 0.5290, 4.84, 0.044, 486, 158, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
787, 3bh1B, 0.5288, 4.75, 0.045, 486, 157, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
788, 4pssA, 0.5283, 1.98, 0.319, 116, 113, MULTICONFORMER MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 100K
789, 4a0rA, 0.5265, 4.78, 0.089, 755, 157, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO DETHIOBIOTIN (DTB).
790, 3bh1C, 0.5265, 4.77, 0.045, 483, 157, CRYSTAL STRUCTURE OF PROTEIN DIP2346 FROM CORYNEBACTERIUM DIPHTHERIAE
791, 4a0gA, 0.5260, 4.75, 0.089, 769, 157, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
792, 4a0hA, 0.5250, 4.66, 0.057, 748, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO 7-KETO 8-AMINO PELARGONIC ACID (KAPA)
793, 4a0hB, 0.5240, 4.68, 0.063, 738, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO 7-KETO 8-AMINO PELARGONIC ACID (KAPA)
794, 4a0gC, 0.5235, 4.69, 0.057, 681, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
795, 4a0gB, 0.5231, 4.70, 0.057, 756, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
796, 4a0rB, 0.5218, 4.69, 0.063, 748, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO DETHIOBIOTIN (DTB).
797, 3a8tA, 0.5195, 4.65, 0.088, 289, 148, PLANT ADENYLATE ISOPENTENYLTRANSFERASE IN COMPLEX WITH ATP
798, 4a0fA, 0.5189, 4.78, 0.096, 731, 156, STRUCTURE OF SELENOMETHIONINE SUBSTITUTED BIFUNCTIONAL DAPA AMINOTRANSFERASE-DETHIOBIOTIN SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
799, 4a0fB, 0.5146, 4.75, 0.057, 735, 157, STRUCTURE OF SELENOMETHIONINE SUBSTITUTED BIFUNCTIONAL DAPA AMINOTRANSFERASE-DETHIOBIOTIN SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
800, 5j1jA, 0.5144, 4.62, 0.075, 273, 146, STRUCTURE OF FLEN-AMPPNP COMPLEX
801, 3ue9D, 0.5135, 4.90, 0.067, 425, 150, CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE (AMPSASE) (PURA) FROM BURKHOLDERIA THAILANDENSIS
802, 1mezA, 0.5130, 4.81, 0.073, 430, 150, STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH SAMP GDP SO4(2-) AND MG(2+)
803, 1lonA, 0.5129, 4.82, 0.073, 431, 150, CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL-IMP GDP AND HADACIDIN
804, 3ez6B, 0.5119, 4.82, 0.101, 394, 149, STRUCTURE OF PARA-ADP COMPLEX:TETRAGONAL FORM
805, 1iweB, 0.5118, 4.76, 0.081, 431, 149, IMP COMPLEX OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE
806, 1lnyA, 0.5116, 4.83, 0.080, 430, 150, CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL- IMP GDP AND MG
807, 1hooB, 0.5115, 4.87, 0.107, 431, 149, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI AT PH 6.5 AND 25 DEGREES CELSIUS
808, 1j4bA, 0.5112, 4.81, 0.067, 432, 150, RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE
809, 5j1jB, 0.5110, 4.58, 0.063, 248, 143, STRUCTURE OF FLEN-AMPPNP COMPLEX
810, 1honB, 0.5104, 4.90, 0.107, 431, 149, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH 6.5 AND 25 DEGREE CELSIUS
811, 1adiB, 0.5103, 4.89, 0.101, 431, 149, STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE AT PH 6.5 AND 25 DEGREES CELSIUS
812, 1mf0A, 0.5098, 4.79, 0.074, 431, 149, STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH AMP GDP HPO4(2-) AND MG(2+)
813, 3ez2A, 0.5097, 4.83, 0.107, 388, 149, PARTITION PROTEIN-ADP COMPLEX
814, 1hopB, 0.5094, 4.90, 0.101, 431, 149, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH 6.5 AND 25 DEGREES CELSIUS
815, 2v40A, 0.5092, 4.71, 0.082, 419, 147, HUMAN ADENYLOSUCCINATE SYNTHETASE ISOZYME 2 IN COMPLEX WITH GDP
816, 2dgnA, 0.5092, 4.78, 0.081, 431, 149, MOUSE MUSCLE ADENYLOSUCCINATE SYNTHETASE PARTIALLY LIGATED COMPLEX WITH GTP 2 -DEOXY-IMP
817, 3ez6A, 0.5077, 4.69, 0.101, 388, 148, STRUCTURE OF PARA-ADP COMPLEX:TETRAGONAL FORM
818, 1honA, 0.5075, 4.66, 0.083, 431, 145, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH 6.5 AND 25 DEGREE CELSIUS
819, 1hooA, 0.5066, 4.78, 0.075, 431, 146, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI AT PH 6.5 AND 25 DEGREES CELSIUS
820, 3eplB, 0.5065, 4.77, 0.063, 402, 143, CRYSTALLOGRAPHIC SNAPSHOTS OF EUKARYOTIC DIMETHYLALLYLTRANSFERASE ACTING ON TRNA: INSIGHT INTO TRNA RECOGNITION AND REACTION MECHANISM
821, 3ue9C, 0.5064, 4.79, 0.062, 426, 145, CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE (AMPSASE) (PURA) FROM BURKHOLDERIA THAILANDENSIS
822, 1adiA, 0.5060, 4.66, 0.076, 431, 144, STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE AT PH 6.5 AND 25 DEGREES CELSIUS
823, 3ez2B, 0.5057, 4.82, 0.107, 394, 149, PARTITION PROTEIN-ADP COMPLEX
824, 1looA, 0.5056, 4.76, 0.088, 431, 148, CRYSTAL STRUCTURE OF THE MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE LIGATED WITH GTP
825, 1hopA, 0.5055, 4.68, 0.076, 431, 144, STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH 6.5 AND 25 DEGREES CELSIUS
826, 1adeA, 0.5039, 5.01, 0.089, 431, 146, STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE PH 7 AT 25 DEGREES CELSIUS
827, 5i34A, 0.5029, 4.69, 0.075, 429, 146, ADENYLOSUCCINATE SYNTHETASE FROM CRYPTOCOCCUS NEOFORMANS COMPLEXED WITH GDP AND IMP
828, 3eplA, 0.5024, 4.60, 0.063, 402, 142, CRYSTALLOGRAPHIC SNAPSHOTS OF EUKARYOTIC DIMETHYLALLYLTRANSFERASE ACTING ON TRNA: INSIGHT INTO TRNA RECOGNITION AND REACTION MECHANISM
829, 1adeB, 0.5017, 4.92, 0.090, 431, 144, STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE PH 7 AT 25 DEGREES CELSIUS
830, 1dj3A, 0.5015, 4.78, 0.122, 432, 147, STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA
831, 1dj2B, 0.5005, 4.79, 0.122, 429, 147, STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA
